ANALYTE MONITORING SYSTEMS AND METHODS OF USE

• US 20120123230A1
• Filed: 10/12/2011
• Published: 05/17/2012
• Est. Priority Date: 10/13/2010
• Status: Abandoned Application

• Current Assignee: Tandem Diabetes Care Incorporated
• Original Assignee: Tandem Diabetes Care Incorporated
• Inventors: BROWN, David, DiPerna, Paul M.
• Application Number:
  US13/272,111
• Publication Number:
  US 20120123230A1
• Time in Patent Office: Days
• US Class Current: 600/316
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14556 by fluorescence A61B5/14555 takes precedence
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: A61M 5/16804 Flow controllers
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

Analyte monitoring systems and methods that make interstitial fluid from a patient'"'"'s body available to one or more sensors disposed outside the patient'"'"'s body. The monitoring systems and methods may be used in conjunction with medicament dispensing systems and methods in order to provide a feedback loop for continuous sensing of analyte levels and corresponding dispensing of medicament based on sensed analyte levels. Dispensing or pumping systems or portions thereof may be used to move a patient'"'"'s interstitial fluid into communication with the one or more sensors.

Claims

1. An analyte monitoring system, comprising:

a proximal housing configured to be affixed to a patient'"'"'s body;

a cannula that is configured for placement through the skin of a patient'"'"'s body, that extends from the proximal housing, and that includes an inner lumen; and

one or more continuous or semi-continuous sensors placed in fluid communication with the inner lumen of the cannula such that the one or more sensors are not in direct contact with the body of the user.

2. The system of claim 1 wherein the one or more sensors comprise at least one glucose sensor.

3. The system of claim 1 wherein the cannula is configured to be placed through the skin of a patient'"'"'s body into any one of the subcutaneous space, the intramuscular space, the dermal layers, or a venous blood vessel.

4. The system of claim 2 wherein the sensor comprises glucose oxidase (GOx) based electrodes or fluorescence based devices.

5. The system of claim 1 further comprising a distal housing that may be detachably connected to the proximal housing.

6. The system of claim 5 wherein the proximal housing comprises a septum in fluid communication with the cannula and distal housing comprises a needle configured to penetrate the septum of the proximal housing upon engagement of the housings.

7. The system of claim 1 further comprising a pump in fluid communication with the inner lumen of the cannula and configured to move fluid out of the patient'"'"'s body, through the inner lumen of the cannula and into fluid communication with the one or more sensors.

8. The system of claim 1 further comprising a processor and user interface configured for processing measurements taken by the one or more sensors and transmitting the processed measurements to a user interface to present the measurements to a patient or caregiver.

9. The system of claim 8 wherein the processor is configured to transmit the processed measurements to a recording medium.

10. The system of claim 1 further comprising a processor configured for processing measurements taken by the one or more sensors and transmitting the processed measurements via a communications link to a remote device.

11. The system of claim 10 wherein the communications link comprises a wireless link, an optical link or a wired link.

12. The system of claim 10 wherein the remote device comprises a user interface for presenting the measurements to a patient or caregiver.

13. The system of claim 10 wherein the remote device comprises an infusion pump.

14. The system of claim 13 wherein the remote infusion device comprises an insulin pump.

15. The system of claim 1 further comprising a processor configured for processing measurements taken by the one or more sensors and transmitting the processed measurements to an integrated infusion device.

16. The system of claim 13 wherein the integrated infusion device comprises an insulin pump.

17. The system of claim 1 wherein the cannula is configured to sample ISF.

18. The system of claim 1 wherein the cannula is configured to transport fluid from the patient'"'"'s body into fluid communication with the one or more sensors by diffusion.

19. The system of claim 18 further comprising a secondary mechanism configured to facilitate movement interstitial fluid out of the patient'"'"'s body into cannula and into fluid communication with the one or more sensors by diffusion.

20. A kit comprising:

one or more of a continuous or semi-continuous analyte monitoring system of claim 1;

an infusion device; and

instructions for using the same.

21. An analyte monitoring system, comprising:

a cannula which has an inner lumen and which is configured to be placed through the skin into the subcutaneous space of the patient'"'"'s body;

a proximal housing that may be affixed to a patient'"'"'s body which comprises a septum that is in fluid communication with an inner lumen of the cannula and that is disposed at a distal end of the cannula;

a distal housing that may be detachably secured to the proximal housing and which comprises a needle configured to penetrate the septum of the proximal housing upon engagement of the housings; and

one or more continuous or semi-continuous sensors placed in fluid communication with the inner lumen of the cannula such that the one or more sensors are not in direct contact with the patient'"'"'s body.

22. The system of claim 21 further comprising a pump in fluid communication with the inner lumen of the cannula configured to move interstitial fluid out of the patient'"'"'s body into cannula and into fluid communication with the one or more sensors.

23. The system of claim 21 further comprising a secondary mechanism configured to facilitate movement interstitial fluid out of the patient'"'"'s body into cannula and into fluid communication with the one or more sensors by diffusion.

24. The system of claim 21 wherein the one or more sensors comprise any one of glucose oxidase (GOx) based electrodes or fluorescence based sensors.

25. The system of claim 21 wherein the cannula is configured to sample ISF of the patient'"'"'s body.